688319.SH
Chengdu Olymvax Biopharmaceuticals, Inc.
SSE · Healthcare · Biotechnology · CN
CNY 27.82
−7.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 120.43x
- P/E 2028E
- 86.56x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 506.67x
- PEG TTM
- —
- Price / book
- 12.97x
- Price / sales
- 14.50x
- Price / cash flow
- 108.42x
Enterprise value
- Enterprise value
- CNY 11.4B
- EV / sales
- 14.68x
- EV / EBITDA
- 163.16x
- EV / EBIT
- 161.72x
- Market cap
- CNY 11.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026